母亲身高是否改变小于或大于胎龄儿与不良围产结局之间的关联?一项回顾性队列研究
该研究基于美国2016–2017年国家卫生统计中心数据,纳入7 325 741例单胎活产,按母亲身高分布低于第10百分位和高于第90百分位定义矮身材和高身材。采用改良泊松回归估计校正风险比,发现母亲身高改变小于胎龄儿和大于胎龄儿与新生儿结局之间的关联。
要点
- 高身材母亲的小于胎龄儿新生儿重症监护病房入住风险最高(aRR 1.98)。
- 高身材母亲的大于胎龄儿新生儿重症监护病房入住风险最低(aRR 0.85)。
- 矮身材母亲的大于胎龄儿新生儿重症监护病房入住和严重新生儿疾病/死亡风险升高。
核心结论
- 母亲身高改变小于胎龄儿和大于胎龄儿状态与新生儿结局之间的关联。
- 这种风险量化可帮助医疗保健提供者监测胎儿生长并优化新生儿护理和随访。
研究设计与样本
- 回顾性队列研究,数据来自美国国家卫生统计中心,2016–2017年,纳入单胎活产N=7 325 741例。
- 矮身材和高身材分别定义为母亲身高分布低于第10百分位和高于第90百分位。
- 采用改良泊松回归估计校正风险比(aRR)和95%置信区间(95%CI)。
主要发现
- 随着母亲身高增加,小于胎龄儿的不良结局风险增加,而大于胎龄儿的不良结局风险降低,与适龄儿相比(p < 0.001)。
- 与平均身高母亲的适龄儿相比,高身材母亲的小于胎龄儿新生儿重症监护病房入住风险最高(aRR 1.98,95%CI 1.91-2.05;p < 0.001)。
- 与平均身高母亲的适龄儿相比,高身材母亲的大于胎龄儿新生儿重症监护病房入住风险最低(aRR 0.85,95%CI 0.82-0.88;p < 0.001)。
- 与平均身高母亲的适龄儿相比,矮身材母亲的大于胎龄儿新生儿重症监护病房入住风险升高(aRR 1.32,95%CI 1.27-1.38),严重新生儿疾病/死亡风险升高(aRR 1.21,95%CI 1.13-1.29)。
临床怎么用
- 作者认为,这种风险量化可帮助医疗保健提供者监测胎儿生长并优化新生儿护理和随访。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the effect of maternal stature on adverse birth outcomes and quantify perinatal risks associated with small- and large-for-gestational age infants (SGA and LGA, respectively) born to mothers of short, average, and tall stature. DESIGN: Retrospective cohort study. SETTING: USA, 2016-2017. POPULATION: Women with a singleton live birth (N = 7 325 741). METHODS: Using data from the National Center for Health Statistics, short and tall stature were defined as <10th and >90th centile of the maternal height distribution. Modified Poisson regression was used to estimate adjusted risk ratios (aRRs) and 95% confidence intervals (95% CIs). MAIN OUTCOME MEASURES: Preterm birth (<37 weeks of gestation), neonatal intensive care unit (NICU) admission and severe neonatal morbidity/mortality (SNMM). RESULTS: With increased maternal height, the risk of adverse outcomes increased in SGA infants and decreased in LGA infants compared with infants appropriate-for-gestational age (AGA) (p < 0.001). Infants who were SGA born to women of tall stature had the highest risk of NICU admission (aRR 1.98, 95% CI 1.91-2.05; p < 0.001), whereas LGA infants born to women of tall stature had the lowest risk (aRR 0.85, 95% CI 0.82-0.88; p < 0.001), compared with AGA infants born to women of average stature. LGA infants born to women of short stature had an increased risk of NICU admission and SNMM, compared with AGA infants born to women of average stature (aRR 1.32, 95% CI 1.27-1.38; aRR 1.21, 95% CI 1.13-1.29, respectively). CONCLUSIONS: Maternal height modifies the association between SGA and LGA status at birth and neonatal outcomes. This quantification of risk can assist healthcare providers in monitoring fetal growth, and optimising neonatal care and follow-up.
引用
- Yearwood L, Bone JN, Wen Q, et al. Does maternal stature modify the association between infants who are small or large for gestational age and adverse perinatal outcomes? A retrospective cohort study. BJOG. 2022. PMID: 36424901. doi:10.1111/1471-0528.17350
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。